Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase 1 placebo-controlled, double-blinded, randomized trial to evaluate the safety and immunogenicity of Ad26-ENVA and Ad35-ENV HIV vaccines in healthy HIV-uninfected adult volunteers
Description
HVTN 091 (IAVI B003/IPCAVD 004) is a Phase I clinical trial to evaluate the safety and immunogenicity of Ad26.ENVA.01 (rAd26) and Ad35-ENV (rAd35).
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.